PHILADELPHIA, Pa. (Ivanhoe Newswire) - Hemophilia, once a death sentence, is now on the verge of having a cure. An inherited disorder, mostly affecting boys, happens when blood doesn’t clot.

Understand key factors influencing hemophilia A treatment decisions and explore the impact of prophylactic vs on-demand therapy on efficacy, safety, and patient outcomes, including joint health, ...

A gene-therapy trial by London researchers has seen remarkable success in finding a long-term cure for hemophilia A. The trial, by researchers at Barts Health NHS (National Health Service) Trust and ...

Joint damage and chronic pain persist in hemophilia, especially in low-resource settings, necessitating innovative therapies and early diagnostic tools. Extended half-life products and emerging ...

Results showed marstacimab was superior to on-demand factor replacement and was noninferior to prophylactic factor-based therapy. The Food and Drug Administration (FDA) has approved Hympavzi ...

(NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for HYMPAVZI ® (marstacimab) to include patients 12 years of age and ...

Patients with the genetic disorder hemophilia A receive factor VIII protein replacement treatments to replenish this clotting protein in their blood, thus preventing dangerous bleeding. Unfortunately, ...

PHILADELPHIA, Pa. - The Ward brothers may have different interests, but Jadon and Roan have more in common than you can see. “Hemophilia is when you have a lot of bleeding,” Roan said. “My blood doesn ...

The FDA approved marstacimab (Hympavzi) for routine prophylaxis to prevent or reduce bleeding episodes in adults and adolescents ages 12 years and older with hemophilia A without factor VIII ...

Gene therapy is part of an increasingly large collection of research fields: those with a huge, useless backlog of innovations. Gene therapy researchers have spent decades developing amazing, ...

Because children with hemophilia lack blood clotting factor proteins, they can be more likely to experience prolonged, heavy bleeding. In cases of severe hemophilia, bleeding may be spontaneous and ...

Hemophilia A is a rare, inherited condition that prevents your blood from clotting the way it should. People with hemophilia A do not make enough of a protein called factor VIII, which normally works ...